SCHEMBL10568268

SCHEMBL10568268

CON1C(=O)CC2(CCN(C(=O)OC(C)(C)C)CC2)C1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 1/20 0.42
USP2 O75604 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ATM Q13315 1/20 0.38
HRH3 Q9Y5N1 4/20 0.38
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
THRB P10828 1/20 0.37
DDB1 Q16531 1/20 0.37
CRBN Q96SW2 1/20 0.37
CTSD P07339 1/20 0.36
CTSE P14091 1/20 0.36
BACE1 P56817 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
HPGD P15428 1/20 0.36
EPHX2 P34913 1/20 0.36
NAMPT P43490 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC8 Q9BY41 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10566700 0.84 USP30 (0.37) USP30USP2SMN1; SMN2ATMHRH3
SCHEMBL10563297 0.84 USP30 (0.39) USP30USP2SMN1; SMN2ATMHRH3
SCHEMBL10565341 0.83 USP30 (0.43) USP30USP2SMN1; SMN2ATMHRH3
SCHEMBL10564287 0.82 GPR119 (0.39) USP30USP2SMN1; SMN2MAPTHDAC1
SCHEMBL10568269 0.81 CHRM2 (0.36) USP2THRBTSHRHPGD
SCHEMBL10565065 0.81 MEN1 (0.45) KDM4EMAPTTSHR
SCHEMBL3498231 0.81 HRH3 (0.41) HRH3KDM4EMAPTTHRBCTSD
SCHEMBL10701654 0.79 CHRM2 (0.43) USP30USP2SMN1; SMN2ATMHRH3
SCHEMBL10563612 0.78 KCNH2 (0.33) SMN1; SMN2KDM4EHPGD
SCHEMBL5895323 0.77 USP2 (0.47) USP30USP2SMN1; SMN2ATMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4804665-A NERVOUS SYSTEM DISORDERS; COGNITION ACTIVATORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1989-02-14 US disclosed